19 June 2013
Keywords: enrollment, continues, voyager, ph, iii, ad, trial
Article | 24 April 2006
USA-based drugmaker Voyager Pharmaceutical says the enrollment in the first Phase III trial of its developmental Alzheimer's disease drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 April 2006
18 June 2013
© 2013 thepharmaletter.com